Skip to main content
Top
Published in: Metabolic Brain Disease 6/2017

Open Access 01-12-2017 | Original Article

Bioenergetic variation is related to autism symptomatology

Authors: Leanna Delhey, Ekim Nur Kilinc, Li Yin, John Slattery, Marie Tippett, Rebecca Wynne, Shannon Rose, Stephen Kahler, Shirish Damle, Agustin Legido, Michael J. Goldenthal, Richard E. Frye

Published in: Metabolic Brain Disease | Issue 6/2017

Login to get access

Abstract

Autism spectrum disorder (ASD) has been associated with mitochondrial dysfunction but few studies have examined the relationship between mitochondrial function and ASD symptoms. We measured Complex I and IV and citrate synthase activities in 76 children with ASD who were not receiving vitamin supplementation or medication. We also measured language using the Preschool Language Scales or Clinical Evaluation of Language Fundamentals, adaptive behavior using the Vineland Adaptive Behavioral Scale, social function using the Social Responsiveness Scale and behavior using Aberrant Behavior Checklist, Childhood Behavior Checklist and the Ohio Autism Clinical Impression Scale. Children with ASD demonstrated significantly greater variation in mitochondrial activity compared to controls with more than expected ASD children having enzyme activity outside of the normal range for Citrate Synthase (24%), Complex I (39%) and Complex IV (11%). Poorer adaptive skills were associated with Complex IV activity lower or higher than average and lower Complex I activity. Poorer social function and behavior was associated with relatively higher Citrate Synthase activity. Similar to previous studies we find both mitochondrial underactivity and overactivity in ASD. This study confirms an expanded variation in mitochondrial activity in ASD and demonstrates, for the first time, that such variations are related to ASD symptoms.
Literature
go back to reference Butter E, Mulick J (2006) The Ohio autism clinical impressions scale (OACIS). Columbus, Children’s Research Institute Butter E, Mulick J (2006) The Ohio autism clinical impressions scale (OACIS). Columbus, Children’s Research Institute
go back to reference Choque Olsson N, Bolte S (2014) Brief report: "quick and (not so) dirty" assessment of change in autism: cross-cultural reliability of the developmental disabilities CGAS and the OSU autism CGI. J Autism Dev Disord 44(7):1773–1778CrossRefPubMed Choque Olsson N, Bolte S (2014) Brief report: "quick and (not so) dirty" assessment of change in autism: cross-cultural reliability of the developmental disabilities CGAS and the OSU autism CGI. J Autism Dev Disord 44(7):1773–1778CrossRefPubMed
go back to reference Constantino JN (2002) The social responsiveness scale. Los Angeles, Western Psychological Services Constantino JN (2002) The social responsiveness scale. Los Angeles, Western Psychological Services
go back to reference Delhey LM, Nur Kilinc E, Yin L, Slattery JC, Tippett ML, Rose S, Bennuri SC, Kahler SG, Damle S, Legido A, Goldenthal MJ, Frye RE (2017) The effect of mitochondrial supplements on mitochondrial activity in children with autism Spectrum disorder. J Clin Med 6(2). doi:10.3390/jcm6020018 Delhey LM, Nur Kilinc E, Yin L, Slattery JC, Tippett ML, Rose S, Bennuri SC, Kahler SG, Damle S, Legido A, Goldenthal MJ, Frye RE (2017) The effect of mitochondrial supplements on mitochondrial activity in children with autism Spectrum disorder. J Clin Med 6(2). doi:10.​3390/​jcm6020018
go back to reference Edgar JC, Khan SY, Blaskey L, Chow VY, Rey M, Gaetz W, Cannon KM, Monroe JF, Cornew L, Qasmieh S, Liu S, Welsh JP, Levy SE, Roberts TP (2015) Neuromagnetic oscillations predict evoked-response latency delays and core language deficits in autism spectrum disorders. J Autism Dev Disord 45(2):395–405CrossRefPubMedPubMedCentral Edgar JC, Khan SY, Blaskey L, Chow VY, Rey M, Gaetz W, Cannon KM, Monroe JF, Cornew L, Qasmieh S, Liu S, Welsh JP, Levy SE, Roberts TP (2015) Neuromagnetic oscillations predict evoked-response latency delays and core language deficits in autism spectrum disorders. J Autism Dev Disord 45(2):395–405CrossRefPubMedPubMedCentral
go back to reference Ezugha H, Goldenthal M, Valencia I, Anderson CE, Legido A, Marks H (2010) 5q14.3 deletion manifesting as mitochondrial disease and autism: case report. J Child Neurol 25(10):1232–1235CrossRefPubMed Ezugha H, Goldenthal M, Valencia I, Anderson CE, Legido A, Marks H (2010) 5q14.3 deletion manifesting as mitochondrial disease and autism: case report. J Child Neurol 25(10):1232–1235CrossRefPubMed
go back to reference Frye RE (2012a) Biomarkers of abnormal energy metabolism in children with autism Spectrum disorder. N A J Med Sci 5(3):141–147CrossRef Frye RE (2012a) Biomarkers of abnormal energy metabolism in children with autism Spectrum disorder. N A J Med Sci 5(3):141–147CrossRef
go back to reference Frye RE (2012b) Novel cytochrome B gene mutations causing mitochondrial disease in autism. J Pediatr Neurol 10:35–40 Frye RE (2012b) Novel cytochrome B gene mutations causing mitochondrial disease in autism. J Pediatr Neurol 10:35–40
go back to reference Frye RE, Naviaux RK (2011) Autistic disorder with complex IV overactivity: a new mitochondrial syndrome. J Pediatr Neurol 9:427–434 Frye RE, Naviaux RK (2011) Autistic disorder with complex IV overactivity: a new mitochondrial syndrome. J Pediatr Neurol 9:427–434
go back to reference Frye RE, Rossignol DA (2011) Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders. Pediatr Res 69(5 Pt 2):41R–47RCrossRefPubMedPubMedCentral Frye RE, Rossignol DA (2011) Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders. Pediatr Res 69(5 Pt 2):41R–47RCrossRefPubMedPubMedCentral
go back to reference Frye RE, Rossignol DA (2016) Identification and treatment of pathophysiological comorbidities of autism Spectrum disorder to achieve optimal outcomes. Clin Med Insights Pediatr 10:43–56CrossRefPubMedPubMedCentral Frye RE, Rossignol DA (2016) Identification and treatment of pathophysiological comorbidities of autism Spectrum disorder to achieve optimal outcomes. Clin Med Insights Pediatr 10:43–56CrossRefPubMedPubMedCentral
go back to reference Frye RE, DeLatorre R, Taylor HB, Slattery J, Melnyk S, Chowdhury N, James SJ (2013a) Metabolic effects of sapropterin treatment in autism spectrum disorder: a preliminary study. Transl Psychiatry 3:e237CrossRefPubMedPubMedCentral Frye RE, DeLatorre R, Taylor HB, Slattery J, Melnyk S, Chowdhury N, James SJ (2013a) Metabolic effects of sapropterin treatment in autism spectrum disorder: a preliminary study. Transl Psychiatry 3:e237CrossRefPubMedPubMedCentral
go back to reference Frye RE, Melnyk S, Macfabe DF (2013b) Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder. Transl Psychiatry 3:e220CrossRefPubMedPubMedCentral Frye RE, Melnyk S, Macfabe DF (2013b) Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder. Transl Psychiatry 3:e220CrossRefPubMedPubMedCentral
go back to reference Frye RE, Slattery J, MacFabe DF, Allen-Vercoe E, Parker W, Rodakis J, Adams JB, Krajmalnik-Brown R, Bolte E, Kahler S, Jennings J, James J, Cerniglia CE, Midtvedt T (2015) Approaches to studying and manipulating the enteric microbiome to improve autism symptoms. Microb Ecol Health Dis 26:26878PubMed Frye RE, Slattery J, MacFabe DF, Allen-Vercoe E, Parker W, Rodakis J, Adams JB, Krajmalnik-Brown R, Bolte E, Kahler S, Jennings J, James J, Cerniglia CE, Midtvedt T (2015) Approaches to studying and manipulating the enteric microbiome to improve autism symptoms. Microb Ecol Health Dis 26:26878PubMed
go back to reference Frye RE, Cox D, Slattery J, Tippett M, Kahler S, Granpeesheh D, Damle S, Legido A, Goldenthal MJ (2016a) Mitochondrial dysfunction may explain symptom variation in Phelan-McDermid syndrome. Sci Rep 6:19544CrossRefPubMedPubMedCentral Frye RE, Cox D, Slattery J, Tippett M, Kahler S, Granpeesheh D, Damle S, Legido A, Goldenthal MJ (2016a) Mitochondrial dysfunction may explain symptom variation in Phelan-McDermid syndrome. Sci Rep 6:19544CrossRefPubMedPubMedCentral
go back to reference Frye RE, Delhey L, Slattery J, Tippett M, Wynne R, Rose S, Kahler SG, Bennuri SC, Melnyk S, Sequeira JM, Quadros E (2016b) Blocking and binding folate receptor alpha autoantibodies identify novel autism Spectrum disorder subgroups. Front Neurosci 10:80PubMedPubMedCentral Frye RE, Delhey L, Slattery J, Tippett M, Wynne R, Rose S, Kahler SG, Bennuri SC, Melnyk S, Sequeira JM, Quadros E (2016b) Blocking and binding folate receptor alpha autoantibodies identify novel autism Spectrum disorder subgroups. Front Neurosci 10:80PubMedPubMedCentral
go back to reference Frye RE, Rose S, Chacko J, Wynne R, Bennuri SC, Slattery JC, Tippett M, Delhey L, Melnyk S, Kahler SG, MacFabe DF (2016c) Modulation of mitochondrial function by the microbiome metabolite propionic acid in autism and control cell lines. Transl Psychiatry 6(10):e927CrossRefPubMedPubMedCentral Frye RE, Rose S, Chacko J, Wynne R, Bennuri SC, Slattery JC, Tippett M, Delhey L, Melnyk S, Kahler SG, MacFabe DF (2016c) Modulation of mitochondrial function by the microbiome metabolite propionic acid in autism and control cell lines. Transl Psychiatry 6(10):e927CrossRefPubMedPubMedCentral
go back to reference Frye RE, Slattery J, Delhey L, Furgerson B, Strickland T, Tippett M, Sailey A, Wynne R, Rose S, Melnyk S, Jill James S, Sequeira JM, Quadros EV (2016d) Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial. Mol Psychiatry. doi:10.1038/mp.2016.168 Frye RE, Slattery J, Delhey L, Furgerson B, Strickland T, Tippett M, Sailey A, Wynne R, Rose S, Melnyk S, Jill James S, Sequeira JM, Quadros EV (2016d) Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial. Mol Psychiatry. doi:10.​1038/​mp.​2016.​168
go back to reference Frye RE, Rose S, Wynne R, Bennuri SC, Blossom S, Gilbert KM, Heilbrun L, Palmer RF (2017a) Oxidative stress challenge uncovers Trichloroacetaldehyde hydrate-induced Mitoplasticity in autistic and control Lymphoblastoid cell lines. Sci Rep 7(1):4478CrossRefPubMedPubMedCentral Frye RE, Rose S, Wynne R, Bennuri SC, Blossom S, Gilbert KM, Heilbrun L, Palmer RF (2017a) Oxidative stress challenge uncovers Trichloroacetaldehyde hydrate-induced Mitoplasticity in autistic and control Lymphoblastoid cell lines. Sci Rep 7(1):4478CrossRefPubMedPubMedCentral
go back to reference Frye RE, Wynne R, Rose S, Slattery J, Delhey L, Tippett M, Kahler SG, Bennuri SC, Melnyk S, Sequeira JM, Quadros EV (2017b) Thyroid dysfunction in children with autism spectrum disorder is associated with folate receptor alpha autoimmune disorder. J Neuroendocrinol 29(3). doi:10.1111/jne.12461 Frye RE, Wynne R, Rose S, Slattery J, Delhey L, Tippett M, Kahler SG, Bennuri SC, Melnyk S, Sequeira JM, Quadros EV (2017b) Thyroid dysfunction in children with autism spectrum disorder is associated with folate receptor alpha autoimmune disorder. J Neuroendocrinol 29(3). doi:10.​1111/​jne.​12461
go back to reference Giulivi C, Zhang YF, Omanska-Klusek A, Ross-Inta C, Wong S, Hertz-Picciotto I, Tassone F, Pessah IN (2010) Mitochondrial dysfunction in autism. JAMA 304(21):2389–2396CrossRefPubMedPubMedCentral Giulivi C, Zhang YF, Omanska-Klusek A, Ross-Inta C, Wong S, Hertz-Picciotto I, Tassone F, Pessah IN (2010) Mitochondrial dysfunction in autism. JAMA 304(21):2389–2396CrossRefPubMedPubMedCentral
go back to reference Goldenthal MJ, Kuruvilla T, Damle S, Salganicoff L, Sheth S, Shah N, Marks H, Khurana D, Valencia I, Legido A (2012) Non-invasive evaluation of buccal respiratory chain enzyme dysfunction in mitochondrial disease: comparison with studies in muscle biopsy. Mol Genet Metab 105(3):457–462CrossRefPubMed Goldenthal MJ, Kuruvilla T, Damle S, Salganicoff L, Sheth S, Shah N, Marks H, Khurana D, Valencia I, Legido A (2012) Non-invasive evaluation of buccal respiratory chain enzyme dysfunction in mitochondrial disease: comparison with studies in muscle biopsy. Mol Genet Metab 105(3):457–462CrossRefPubMed
go back to reference Goldenthal MJ, Damle S, Sheth S, Shah N, Melvin J, Jethva R, Hardison H, Marks H, Legido A (2015) Mitochondrial enzyme dysfunction in autism spectrum disorders; a novel biomarker revealed from buccal swab analysis. Biomark Med 9(10):957–965CrossRefPubMed Goldenthal MJ, Damle S, Sheth S, Shah N, Melvin J, Jethva R, Hardison H, Marks H, Legido A (2015) Mitochondrial enzyme dysfunction in autism spectrum disorders; a novel biomarker revealed from buccal swab analysis. Biomark Med 9(10):957–965CrossRefPubMed
go back to reference Gomez-Sanchez R, Yakhine-Diop SM, Bravo-San Pedro JM, Pizarro-Estrella E, Rodriguez-Arribas M, Climent V, Martin-Cano FE, Gonzalez-Soltero ME, Tandon A, Fuentes JM, Gonzalez-Polo RA (2016) PINK1 deficiency enhances autophagy and mitophagy induction. Mol Cell Oncol 3(2):e1046579CrossRefPubMed Gomez-Sanchez R, Yakhine-Diop SM, Bravo-San Pedro JM, Pizarro-Estrella E, Rodriguez-Arribas M, Climent V, Martin-Cano FE, Gonzalez-Soltero ME, Tandon A, Fuentes JM, Gonzalez-Polo RA (2016) PINK1 deficiency enhances autophagy and mitophagy induction. Mol Cell Oncol 3(2):e1046579CrossRefPubMed
go back to reference Hallmayer J, Cleveland S, Torres A, Phillips J, Cohen B, Torigoe T, Miller J, Fedele A, Collins J, Smith K, Lotspeich L, Croen LA, Ozonoff S, Lajonchere C, Grether JK, Risch N (2011) Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry 68(11):1095–1102CrossRefPubMedPubMedCentral Hallmayer J, Cleveland S, Torres A, Phillips J, Cohen B, Torigoe T, Miller J, Fedele A, Collins J, Smith K, Lotspeich L, Croen LA, Ozonoff S, Lajonchere C, Grether JK, Risch N (2011) Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry 68(11):1095–1102CrossRefPubMedPubMedCentral
go back to reference Hanratty J, Livingstone N, Robalino S, Terwee CB, Glod M, Oono IP, Rodgers J, Macdonald G, McConachie H (2015) Systematic review of the measurement properties of tools used to measure behaviour problems in young children with autism. PLoS One 10(12):e0144649CrossRefPubMedPubMedCentral Hanratty J, Livingstone N, Robalino S, Terwee CB, Glod M, Oono IP, Rodgers J, Macdonald G, McConachie H (2015) Systematic review of the measurement properties of tools used to measure behaviour problems in young children with autism. PLoS One 10(12):e0144649CrossRefPubMedPubMedCentral
go back to reference Hus V, Bishop S, Gotham K, Huerta M, Lord C (2013) Factors influencing scores on the social responsiveness scale. J Child Psychol Psychiatry 54(2):216–224CrossRefPubMed Hus V, Bishop S, Gotham K, Huerta M, Lord C (2013) Factors influencing scores on the social responsiveness scale. J Child Psychol Psychiatry 54(2):216–224CrossRefPubMed
go back to reference Kaat AJ, Lecavalier L, Aman MG (2014) Validity of the aberrant behavior checklist in children with autism spectrum disorder. J Autism Dev Disord 44(5):1103–1116CrossRefPubMed Kaat AJ, Lecavalier L, Aman MG (2014) Validity of the aberrant behavior checklist in children with autism spectrum disorder. J Autism Dev Disord 44(5):1103–1116CrossRefPubMed
go back to reference Legido A, Jethva R, Goldenthal MJ (2013) Mitochondrial dysfunction in autism. Semin Pediatr Neurol 20(3):163–175CrossRefPubMed Legido A, Jethva R, Goldenthal MJ (2013) Mitochondrial dysfunction in autism. Semin Pediatr Neurol 20(3):163–175CrossRefPubMed
go back to reference Manucha W (2017) Mitochondrial dysfunction associated with nitric oxide pathways in glutamate neurotoxicity. Clin Investig Arterioscler 29(2):92–97CrossRefPubMed Manucha W (2017) Mitochondrial dysfunction associated with nitric oxide pathways in glutamate neurotoxicity. Clin Investig Arterioscler 29(2):92–97CrossRefPubMed
go back to reference Missiroli S, Morganti C, Giorgi C, Pinton P (2016) Methods to study PTEN in mitochondria and endoplasmic reticulum. Methods Mol Biol 1388:187–212CrossRefPubMed Missiroli S, Morganti C, Giorgi C, Pinton P (2016) Methods to study PTEN in mitochondria and endoplasmic reticulum. Methods Mol Biol 1388:187–212CrossRefPubMed
go back to reference Murray MJ, Mayes SD, Smith LA (2011) Brief report: excellent agreement between two brief autism scales (checklist for autism Spectrum disorder and social responsiveness scale) completed independently by parents and the autism diagnostic interview-revised. J Autism Dev Disord 41(11):1586–1590CrossRefPubMed Murray MJ, Mayes SD, Smith LA (2011) Brief report: excellent agreement between two brief autism scales (checklist for autism Spectrum disorder and social responsiveness scale) completed independently by parents and the autism diagnostic interview-revised. J Autism Dev Disord 41(11):1586–1590CrossRefPubMed
go back to reference Napoli E, Wong S, Hertz-Picciotto I, Giulivi C (2014) Deficits in bioenergetics and impaired immune response in granulocytes from children with autism. Pediatrics 133(5):e1405–e1410CrossRefPubMedPubMedCentral Napoli E, Wong S, Hertz-Picciotto I, Giulivi C (2014) Deficits in bioenergetics and impaired immune response in granulocytes from children with autism. Pediatrics 133(5):e1405–e1410CrossRefPubMedPubMedCentral
go back to reference Niyazov DM, Kahler SG, Frye RE (2016) Primary mitochondrial disease and secondary mitochondrial dysfunction: importance of distinction for diagnosis and treatment. Mol Syndromol 7(3):122–137CrossRefPubMedPubMedCentral Niyazov DM, Kahler SG, Frye RE (2016) Primary mitochondrial disease and secondary mitochondrial dysfunction: importance of distinction for diagnosis and treatment. Mol Syndromol 7(3):122–137CrossRefPubMedPubMedCentral
go back to reference Norkett R, Modi S, Birsa N, Atkin TA, Ivankovic D, Pathania M, Trossbach SV, Korth C, Hirst WD, Kittler JT (2016) DISC1-dependent regulation of mitochondrial dynamics controls the morphogenesis of complex neuronal dendrites. J Biol Chem 291(2):613–629CrossRefPubMed Norkett R, Modi S, Birsa N, Atkin TA, Ivankovic D, Pathania M, Trossbach SV, Korth C, Hirst WD, Kittler JT (2016) DISC1-dependent regulation of mitochondrial dynamics controls the morphogenesis of complex neuronal dendrites. J Biol Chem 291(2):613–629CrossRefPubMed
go back to reference Palmieri L, Papaleo V, Porcelli V, Scarcia P, Gaita L, Sacco R, Hager J, Rousseau F, Curatolo P, Manzi B, Militerni R, Bravaccio C, Trillo S, Schneider C, Melmed R, Elia M, Lenti C, Saccani M, Pascucci T, Puglisi-Allegra S, Reichelt KL, Persico AM (2010) Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1. Mol Psychiatry 15(1):38–52CrossRefPubMed Palmieri L, Papaleo V, Porcelli V, Scarcia P, Gaita L, Sacco R, Hager J, Rousseau F, Curatolo P, Manzi B, Militerni R, Bravaccio C, Trillo S, Schneider C, Melmed R, Elia M, Lenti C, Saccani M, Pascucci T, Puglisi-Allegra S, Reichelt KL, Persico AM (2010) Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1. Mol Psychiatry 15(1):38–52CrossRefPubMed
go back to reference Rattaz C, Michelon C, Baghdadli A (2015) Symptom severity as a risk factor for self-injurious behaviours in adolescents with autism spectrum disorders. J Intellect Disabil Res 59(8):730–740CrossRefPubMed Rattaz C, Michelon C, Baghdadli A (2015) Symptom severity as a risk factor for self-injurious behaviours in adolescents with autism spectrum disorders. J Intellect Disabil Res 59(8):730–740CrossRefPubMed
go back to reference Rose S, Melnyk S, Pavliv O, Bai S, Nick TG, Frye RE, James SJ (2012) Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain. Transl Psychiatry 2:e134CrossRefPubMedPubMedCentral Rose S, Melnyk S, Pavliv O, Bai S, Nick TG, Frye RE, James SJ (2012) Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain. Transl Psychiatry 2:e134CrossRefPubMedPubMedCentral
go back to reference Rose S, Frye RE, Slattery J, Wynne R, Tippett M, Melnyk S, James SJ (2014a) Oxidative stress induces mitochondrial dysfunction in a subset of autistic lymphoblastoid cell lines. Transl Psychiatry 4:e377CrossRefPubMedPubMedCentral Rose S, Frye RE, Slattery J, Wynne R, Tippett M, Melnyk S, James SJ (2014a) Oxidative stress induces mitochondrial dysfunction in a subset of autistic lymphoblastoid cell lines. Transl Psychiatry 4:e377CrossRefPubMedPubMedCentral
go back to reference Rose S, Frye RE, Slattery J, Wynne R, Tippett M, Pavliv O, Melnyk S, James SJ (2014b) Oxidative stress induces mitochondrial dysfunction in a subset of autism lymphoblastoid cell lines in a well-matched case control cohort. PLoS One 9(1):e85436CrossRefPubMedPubMedCentral Rose S, Frye RE, Slattery J, Wynne R, Tippett M, Pavliv O, Melnyk S, James SJ (2014b) Oxidative stress induces mitochondrial dysfunction in a subset of autism lymphoblastoid cell lines in a well-matched case control cohort. PLoS One 9(1):e85436CrossRefPubMedPubMedCentral
go back to reference Rose S, Frye RE, Slattery J, Wynne R, Tippett M, Melnyk S, James SJ (2015a) Oxidative stress induces mitochondrial dysfunction in a subset of autistic lymphoblastoid cell lines. Transl Psychiatry 5:e526CrossRefPubMedPubMedCentral Rose S, Frye RE, Slattery J, Wynne R, Tippett M, Melnyk S, James SJ (2015a) Oxidative stress induces mitochondrial dysfunction in a subset of autistic lymphoblastoid cell lines. Transl Psychiatry 5:e526CrossRefPubMedPubMedCentral
go back to reference Rose S, Wynne R, Frye RE, Melnyk S, James SJ (2015b) Increased susceptibility to ethylmercury-induced mitochondrial dysfunction in a subset of autism lymphoblastoid cell lines. J Toxicol 2015:573701CrossRefPubMedPubMedCentral Rose S, Wynne R, Frye RE, Melnyk S, James SJ (2015b) Increased susceptibility to ethylmercury-induced mitochondrial dysfunction in a subset of autism lymphoblastoid cell lines. J Toxicol 2015:573701CrossRefPubMedPubMedCentral
go back to reference Rose S, Bennuri SC, Wynne R, Melnyk S, James SJ, Frye RE (2017) Mitochondrial and redox abnormalities in autism lymphoblastoid cells: a sibling control study. FASEB J 31(3):904–909CrossRefPubMed Rose S, Bennuri SC, Wynne R, Melnyk S, James SJ, Frye RE (2017) Mitochondrial and redox abnormalities in autism lymphoblastoid cells: a sibling control study. FASEB J 31(3):904–909CrossRefPubMed
go back to reference Rossignol DA, Frye RE (2012) Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol Psychiatry 17(3):290–314CrossRefPubMed Rossignol DA, Frye RE (2012) Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol Psychiatry 17(3):290–314CrossRefPubMed
go back to reference Rossignol DA, Frye RE (2014) Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism. Front Physiol 5:150CrossRefPubMedPubMedCentral Rossignol DA, Frye RE (2014) Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism. Front Physiol 5:150CrossRefPubMedPubMedCentral
go back to reference Verly M, Verhoeven J, Zink I, Mantini D, Van Oudenhove L, Lagae L, Sunaert S, Rommel N (2014) Structural and functional underconnectivity as a negative predictor for language in autism. Hum Brain Mapp 35(8):3602–3615CrossRefPubMed Verly M, Verhoeven J, Zink I, Mantini D, Van Oudenhove L, Lagae L, Sunaert S, Rommel N (2014) Structural and functional underconnectivity as a negative predictor for language in autism. Hum Brain Mapp 35(8):3602–3615CrossRefPubMed
go back to reference Vijitruth R, Liu M, Choi DY, Nguyen XV, Hunter RL, Bing G (2006) Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease. J Neuroinflammation 3:6CrossRefPubMedPubMedCentral Vijitruth R, Liu M, Choi DY, Nguyen XV, Hunter RL, Bing G (2006) Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease. J Neuroinflammation 3:6CrossRefPubMedPubMedCentral
go back to reference Volden J, Smith IM, Szatmari P, Bryson S, Fombonne E, Mirenda P, Roberts W, Vaillancourt T, Waddell C, Zwaigenbaum L, Georgiades S, Duku E, Thompson A (2011) Using the preschool language scale, fourth edition to characterize language in preschoolers with autism spectrum disorders. Am J Speech Lang Pathol 20(3):200–208CrossRefPubMed Volden J, Smith IM, Szatmari P, Bryson S, Fombonne E, Mirenda P, Roberts W, Vaillancourt T, Waddell C, Zwaigenbaum L, Georgiades S, Duku E, Thompson A (2011) Using the preschool language scale, fourth edition to characterize language in preschoolers with autism spectrum disorders. Am J Speech Lang Pathol 20(3):200–208CrossRefPubMed
go back to reference Wallace KB (2014) Drug-induced mitochondrial neuropathy in children: a conceptual framework for critical windows of development. J Child Neurol 29(9):1241–1248CrossRefPubMed Wallace KB (2014) Drug-induced mitochondrial neuropathy in children: a conceptual framework for critical windows of development. J Child Neurol 29(9):1241–1248CrossRefPubMed
go back to reference Yorns WR Jr, Valencia I, Jayaraman A, Sheth S, Legido A, Goldenthal MJ (2012) Buccal swab analysis of mitochondrial enzyme deficiency and DNA defects in a child with suspected myoclonic epilepsy and ragged red fibers (MERRF). J Child Neurol 27(3):398–401CrossRefPubMed Yorns WR Jr, Valencia I, Jayaraman A, Sheth S, Legido A, Goldenthal MJ (2012) Buccal swab analysis of mitochondrial enzyme deficiency and DNA defects in a child with suspected myoclonic epilepsy and ragged red fibers (MERRF). J Child Neurol 27(3):398–401CrossRefPubMed
go back to reference Zablotsky B, Black LI, Maenner MJ, Schieve LA, Blumberg SJ (2015) Estimated prevalence of autism and other developmental disabilities following questionnaire changes in the 2014 National Health Interview Survey. Natl Health Stat Report 87:1–20 Zablotsky B, Black LI, Maenner MJ, Schieve LA, Blumberg SJ (2015) Estimated prevalence of autism and other developmental disabilities following questionnaire changes in the 2014 National Health Interview Survey. Natl Health Stat Report 87:1–20
go back to reference Zheng X, Boyer L, Jin M, Kim Y, Fan W, Bardy C, Berggren T, Evans RM, Gage FH and Hunter T (2016) Alleviation of neuronal energy deficiency by mTOR inhibition as a treatment for mitochondria-related neurodegeneration. Elife 5. doi:10.7554/eLife.13378 Zheng X, Boyer L, Jin M, Kim Y, Fan W, Bardy C, Berggren T, Evans RM, Gage FH and Hunter T (2016) Alleviation of neuronal energy deficiency by mTOR inhibition as a treatment for mitochondria-related neurodegeneration. Elife 5. doi:10.​7554/​eLife.​13378
Metadata
Title
Bioenergetic variation is related to autism symptomatology
Authors
Leanna Delhey
Ekim Nur Kilinc
Li Yin
John Slattery
Marie Tippett
Rebecca Wynne
Shannon Rose
Stephen Kahler
Shirish Damle
Agustin Legido
Michael J. Goldenthal
Richard E. Frye
Publication date
01-12-2017
Publisher
Springer US
Published in
Metabolic Brain Disease / Issue 6/2017
Print ISSN: 0885-7490
Electronic ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-017-0087-0

Other articles of this Issue 6/2017

Metabolic Brain Disease 6/2017 Go to the issue